JPMORGAN CHASE & CO - KEMPHARM INC ownership

KEMPHARM INC's ticker is KMPH and the CUSIP is 488445206. A total of 82 filers reported holding KEMPHARM INC in Q1 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of KEMPHARM INC
ValueSharesWeighting
Q3 2023$112,128
-20.6%
23,263
-15.9%
0.00%
Q2 2023$141,138
+3428.4%
27,674
+3457.1%
0.00%
Q1 2023$4,000
+99900.0%
7780.0%0.00%
Q4 2022$4
-100.0%
778
-64.2%
0.00%
Q3 2022$14,000
+100.0%
2,175
+39.2%
0.00%
Q2 2022$7,000
-92.3%
1,562
-91.4%
0.00%
Q1 2022$91,000
-26.0%
18,095
+28.3%
0.00%
Q4 2021$123,000
-10.9%
14,105
-5.1%
0.00%
Q3 2021$138,000
-2.1%
14,867
+35.5%
0.00%
Q2 2021$141,00010,9720.00%
Other shareholders
KEMPHARM INC shareholders Q1 2022
NameSharesValueWeighting ↓
Retirement Planning Co of New England, Inc. 327,583$1,801,7071.09%
Mystic Asset Management, Inc. 177,533$976,4320.54%
GREAT POINT PARTNERS LLC 347,824$1,913,0320.38%
Kovack Advisors, Inc. 122,822$675,5210.09%
City State Bank 14,224$780.04%
Arete Wealth Advisors, LLC 82,290$4530.04%
VisionPoint Advisory Group, LLC 10,217$49,8590.02%
Laurion Capital Management LP 571,200$3,141,6000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 95,143$523,2870.01%
Janney Montgomery Scott LLC 528,755$2,9080.01%
View complete list of KEMPHARM INC shareholders